Obsession, Compliance, and Really Good Soda: An Inside Look at Looper

Sometimes, it’s good to be obsessed. In an industry heavy with similar products, it’s often the little things on the margins that separate great products from good ones. 

At least that’s how Looper sees it. The decision makers behind the high-potency alt-cannabinoid brand pride themselves on their ability to pore over the smallest particulars. 

That’s where they find an advantage. 

“We obsess over the details that most people skip,” explains Looper Marketing Director Nathan Tagalag. “That means clean inputs, pure distillate with no filler or additives, rigorous testing, and packaging that actually reflects what’s inside.”

That works on two levels. Looper packages its alt-cannabinoids in charismatic boxes that emotionally evoke each product’s effects while plainly stating its contents. The unstated goal is to simplify the experience. Tagalag wants to guide customers toward Looper products because they produce deliberate results. The company thoroughly tests its wares to ensure every vape, pre-roll, extract, and soda delivers predictable, high-quality encounters. 

“We think a lot about experience, how a product makes you feel, how it fits into your day, and how approachable it is,” he added. “Our audience is typically adults over 21 years of age who are curious, informed, and intentional. They’re the people who want an elevated experience without the stigma or confusion that, sadly, still exists around cannabis. And while they range from first-time explorers to seasoned users, they all care about quality, transparency, and consistency.” 

The Goods

The result of that careful approach to cannabinoids came late last year, when Looper’s line of Delta 9 sodas was recognized with top honors at the 2025 High Spirit Awards

Its 50mg Pineapple, Orange, and Grape flavors took home Platinum, Gold, and Silver medals in the category of Best Infused Soda/Best Infused Beverage. The competition was created by the L.A. Spirits Awards, which typically recognizes outstanding alcoholic products. The cannabis-infused portion debuted last year in recognition of the popularity and quality of cannabis-based drinks. 

“It all comes down to formulation. We don’t overload our drinks or try to mask poor inputs with sweetness. Instead, we focus on balance and clean Delta 9 dosing. We want it to taste like something you’d actually want to drink again,” Tagalag said. “This recognition was validating because it comes from people who understand both the beverage craft and cannabinoid performance.” 

Building off that success, Looper launched three new flavors in March: Toka Cola, which features a more traditional soda pop taste; Diet Toka Cola; and Lemon, which goes down like Sprite. 

Looper’s beverages aren’t the only products whose reputation is on the rise. Another new addition to its line, Booster Shots, has been building a reputation. Created from the same formulations as their terp-heavy vapes, Booster Shots are syringes filled with cannabinoid-infused oil that’s meant to enhance the punch of vape carts, although creative users have discovered numerous other uses. 

“We’ve heard from a lot of our customers who are using this as an additive. They put it on top of their pre-roll, or they add it to their gummies or maybe a cookie or a brownie. Some even just, um, put it in their rig and just partake,” Tagalag said. 

The Tobacco Pivot 

Booster Shots’ popularity stems from Looper’s reputation for hard-hitting vapes. Reading online reviews about the brand’s disposables, you’d think every customer just had a religious experience. But the hype is well-earned. Before joining the counterculture industry, the team behind Looper functioned as an e-liquid company. They jumped to alt-cannabinoids after deciding the new laws governing tobacco products were too suffocating. Yet, in an ironic twist, that issue has become the core of their brand’s identity. 

“The industry definitely has matured rapidly in the last 10 years. Regulations are tightened. Consumers got smarter, and the hype phase ended,” Tagalag said. “For us, it meant doubling down on compliance, tightening our formulations, and being more disciplined operationally. Thanks to our history, we’re pretty comfortable moving around regulations.”

The lessons Looper took from its days in the tobacco vape industry taught the company to see around corners. The company’s highest priority, Tagalag said, is keeping products shelf-legal. 

“Rules change fast, and enforcement isn’t always consistent; that keeps everyone on edge,” he says. “At the same time, what excites us is how sophisticated consumers have become. People are asking better questions, demanding cleaner products, and exploring cannabinoids beyond THC alone. That curiosity is pushing the industry forward, and it’s exactly the environment Looper was built for.”

Not that it’s easy. The raft of changes that happened in 2025 alone is enough to cause serious legal headaches for even the most careful cannabinoid maker. Tagalag, however, chooses to remain optimistic. He sees recent crackdowns as a step toward greater acceptance and legitimacy. 

“There’s a lot of regulation and a lot of banning going on. I think the best way to come out of that is to better regulate the products, making sure they’re being manufactured in a safe environment with all the right warnings and verbiage on the packaging. We as an industry need to be fully transparent with the consumer, just to give them the assurance that these are safe products and we’re not hiding anything,” he said. “Having transparency from every brand would definitely help the industry. I think that, five years from now, that’s where we’ll be, and it will really be a good thing.” 

Recent Articles

Dr. Macias first fell in love with science while studying at Howard University, where she completed her undergraduate studies and later earned her PhD in cellular and molecular biology. While at Howard, she became especially interested in cancer research due to personal ties. Growing up in a Creole family and predominantly Black community in Louisiana, Dr. Macias watched many women around her battle breast cancer, so at Howard, she decided to focus her research on the BRCA1 gene.
It’s almost amazing that the same institutions that brought us the 2008 financial crisis have a problem with selling glass pipes. Almost. The truth is that an industry's past sins are only held against it when the money isn’t right. Big banks were willing to risk cratering the U.S. housing market because the profits were too good to ignore. But the cannabis industry rolls a different kind of paper, so instead of a slap on the wrist, it gets a surcharge.
Smokeshop and counterculture enthusiasts enjoy discovery as part of the experience. Customers enjoy browsing. When they walk into a shop, they don't simply grab a product and leave. They look for something new. This is the main reason flyers and posters still work. Smokeshops and dispensaries are highly visual environments. You want to see bold artwork, psychedelic graphics, and street-style posters that naturally capture attention.
The use of cannabis in professional sports has always been a controversial subject. While some are firm believers that all substances should be banned from professional sports altogether, most people aren’t thinking about cannabis when they’re discussing performance-enhancing drugs (PEDs). In fact, there have been countless cannabis users in the world of professional sports throughout the years; some of whom are more open about their love for the plant than others.
North Carolina might save us all. A new state bill may be the industry’s best option to save itself from demise when new federal cannabinoid bans take effect in November. And it could use your support.
Hemp is often considered for the things that it is not. It is not intoxicating, it is not illegal, and it is not marijuana. However, now we are seeing a focus back to what it can be. The plant is moving into the level of wine and chocolate and becoming a movement and a culture.
It’s been several months since President Donald Trump signed an executive order to reschedule cannabis from Schedule I to Schedule III within the Controlled Substances Act (CSA). On paper, the recent executive order, entitled “Increasing Medical Marijuana and Cannabidiol Research,” is a huge step in the right direction for cannabis smokers across the country.
For years, we’ve been told that this industry is the Wild West: a place where the only law amounts to whatever the guy with the gun says. But over the last 12 months, state governments have passed a spate of new regulations that promise to swap the relative lawlessness of poor enforcement of vague rules with real law and order.